Active Surveillance Versus Intervention for Small Renal Masses: Imaging Modalities and Capabilities

At the AUA 2024 Annual Meeting, Daniel Joyce, MD, of Vanderbilt University Medical Center, speaks with Phillip Pierorazio, MD, of University of Pennsylvania Medicine, on appropriate surveillance versus primary intervention for clinical T1a kidney tumors.

Together, they consider how renal biopsies modulate management plans, presented results the from the 15-year DISSRM prospective comparative study, and more.